Search results

  1. forestglip

    Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control study, 2026, Missailidis et

    Were the adjusted p-values used in the paper? I see that there are FDR values in table S2 for the pathways, in which only vitamin B6 metabolism is below .05. But the text and figure 1A seem to be based on the raw p-values.
  2. forestglip

    Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID, 2025, Petrov et al

    Oh okay, I thought you were mainly aiming for the binning aspect, not necessarily keeping it asymmetrical like a standard histogram.
  3. forestglip

    Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID, 2025, Petrov et al

    Oh I understand. Basically bin them to the width of one of the circles. Yeah, I mean like here's a paper where after they corrected an error in their plot, they switched to the binned dot plot/histogram type visualization. I like the exact values on the left better. Edit: But I can see an...
  4. forestglip

    Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID, 2025, Petrov et al

    I'm not sure what you mean by round to the nearest point. Is it difficult to compare groups in the plot I shared? Along with an overlaid median line and maybe box plot, it seems to be good to see differences in distribution. I guess a histogram looks a little less visually messy.
  5. forestglip

    Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID, 2025, Petrov et al

    It's basically the same thing except the exact value can be shown in a swarm plot, instead of being put in bins of arbitrary width in a histogram. But swarm plots where the points are overlapping, like in this paper, don't seem as helpful because you can't see the distribution clearly.
  6. forestglip

    Cognitive assessment in ME/CFS: a cognitive substudy of the multi-site clinical assessment of ME/CFS (MCAM), 2024, Lange, Unger +

    The Groton Maze Learning task seemed to produce the largest differences in this study. A while ago, I wanted to see if I might be able to do the task myself somehow on a regular basis to track cognition. I couldn't find any sources where it was freely available, so I tried to piece the...
  7. forestglip

    Evaluating working memory functioning in individuals with [ME/CFS]: a systematic review and meta-analysis, 2026, Penson et al

    Yeah, I like that idea. Any idea why the digit span plot doesn't include the more recent MCAM study (Lange 2024)? I haven't looked at it in a while, but it was pretty large and seems to have included backwards digit span tests which were non-significant.
  8. forestglip

    Evaluating working memory functioning in individuals with [ME/CFS]: a systematic review and meta-analysis, 2026, Penson et al

    Thanks @ME/CFS Science Blog for the quick summary on Bluesky. The nearly consistent direction of effect in the plots is interesting.
  9. forestglip

    Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID, 2025, Petrov et al

    My guess is that all the points with identical values were below the limit of detection, and were just given an abitrary low value. That might be what this sentence is talking about: Edit: Though that doesn't explain why some points are also below this value, and one is even at 0.
  10. forestglip

    Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID, 2025, Petrov et al

    I'm not a fan of the overlapping points here making it hard to see exactly how many there are. But otherwise these types of plots are very common in papers on biological markers. As far as I can recall, histograms are rarely used for something like comparing cell counts.
  11. forestglip

    Germany's "National Decade Against Post-Infectious Diseases"

    I feel like I'm missing something. Is Uplinza funding separate from the National Decade against Post-Infectious Diseases? From the linked page: From previous post:
  12. forestglip

    2025: looking back on a year of ME/CFS research

    Wow, an article about your blog from ME Research UK. Congratulations! ME Research UK: 'The “most interesting ME/CFS research studies of the year” included work from the DecodeME team, Assistant Professor Rob Wüst, Dr Bupesh Prusty, Dr Nuno Sepúlveda, and Professor Carmen Schiebenbogen
  13. forestglip

    Trial Report REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial, 2026, Huang et al

    Why a red flag if they're studying patients with fatigue-associated long COVID, not necessarily PEM LC? My understanding/sense is that there are many with fatigue due to LC but they don't necessarily have PEM.
  14. forestglip

    Preprint Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 … Antibodies Targeting Envelope and Nucleocapsid Proteins, 2025, Kwisa et al.

    For some reason, this was posted to a different preprint server. The only substantive change to the abstract was replacing "PASC" with "long COVID". And the author list looks slightly different. Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and...
  15. forestglip

    Trial Report REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial, 2026, Huang et al

    REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial [Line breaks added] Background Post-COVID syndrome affects a substantial proportion of individuals worldwide and imposes significant healthcare and economic burdens. Fatigue is one of...
  16. forestglip

    Genome-wide meta-analysis identifies genetic risk loci for mono- and polyneuropathies in 983 477 individuals, 2026, Broberg et al.

    Table 5: It looks like alleles of this haplotype increase risk of neuropathies. This is the same haplotype that looked to be protective against ME/CFS in Lande 2020, with supporting evidence from other studies:
  17. forestglip

    Genome-wide meta-analysis identifies genetic risk loci for mono- and polyneuropathies in 983 477 individuals, 2026, Broberg et al.

    Also DecodeME. While it didn't quite reach the genome-wide significance threshold, it had a p-value of 2.48x10-7, so there's still a good chance it's a real finding. The locus can be seen in this post.
  18. forestglip

    Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control study, 2026, Missailidis et

    Yeah. Well more specifically no genetic difference in this cohort. It could still be involved without having significant mutations.
  19. forestglip

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    The whole concept of ME/CFS seems less helpful to me as a whole than just the concept of PEM. ME/CFS seems like a bunch of random symptoms put together because they seem to somewhat occur together and which help put people in boxes at the doctor's office. And even with this ME/CFS diagnosis...
Back
Top Bottom